Further investigation of these effects revealed that nintedanib could promote tumor vascular normalization and increase T cell and DC infiltration and activation while reshaping the TIME (enhanced IFN-γ responses and MHC-I-mediated antigen presentation). Here, IFNG is linked to neoplasm.